Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huadong Tang

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|October 5, 2015
Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonistsXing Dai, Andrew Stamford, Hong Liu, et al.
Frontiers in Endocrinology|January 2, 2026
Correlation between intrasellar pressure, pituitary adenoma invasiveness, pituitary dysfunction, and apoplexyShan Xie, Zhilin Shao, Dongqi Shao, et al.
Bioorganic & Medicinal Chemistry|April 15, 2015
Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitorsUmar Faruk Mansoor, Angie R Angeles, Chaoyang Dai, et al.
BMC Cancer|November 2, 2023
The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapyXiulan Li, Xiaoke Wei, Xin Liu, et al.
Frontiers in Microbiology|March 20, 2025
HPV integration profiling using nanopore sequencing and association with cervical precancerous lesionYing Hou, Shoufeng Ni, Xin Liu, et al.
Molecular Cancer Therapeutics|October 28, 2010
SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeuticsAndrea D Basso, Ming Liu, Chaoyang Dai, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 DiabetesSanthosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|October 5, 2015
Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonistsXing Dai, Andrew Stamford, Hong Liu, et al.
Frontiers in Endocrinology|January 2, 2026
Correlation between intrasellar pressure, pituitary adenoma invasiveness, pituitary dysfunction, and apoplexyShan Xie, Zhilin Shao, Dongqi Shao, et al.
Bioorganic & Medicinal Chemistry|April 15, 2015
Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitorsUmar Faruk Mansoor, Angie R Angeles, Chaoyang Dai, et al.
BMC Cancer|November 2, 2023
The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapyXiulan Li, Xiaoke Wei, Xin Liu, et al.
Frontiers in Microbiology|March 20, 2025
HPV integration profiling using nanopore sequencing and association with cervical precancerous lesionYing Hou, Shoufeng Ni, Xin Liu, et al.
Molecular Cancer Therapeutics|October 28, 2010
SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeuticsAndrea D Basso, Ming Liu, Chaoyang Dai, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 DiabetesSanthosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, et al.
Pageof 5